Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Rhinosinusitis disorders are almost regularly associated to Cystic Fibrosis (CF). The basic
defect in CF is a dysfunction of chloride channels in exocrine glands which equally concerns
upper airway mucosa. It leads to retention of secretions and consecutive chronic inflammation
with bacterial superinfection.
In CF rhinosinusitis can restrict quality of life, give cause to repeated ear, nose, and
throat (ENT) surgery and accelerate disease progression by bacterial acquisition into the
airways.
The multicenter, randomized, double-blind, placebo-controlled, prospective clinical trial
aims at the evaluation of a sino-nasal inhalation of sodium chloride 6% compared to isotonic
saline with respect to ENT-related quality of life which is influenced by mucus retention and
the resulting inflammation.